Quantum Kidney Care Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 0.60 M
- Company Age 21 Year, 19 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -59.95%
- Profit Growth 37.60%
- Ebitda -97.33%
- Net Worth -273.48%
- Total Assets -19.44%
About Quantum Kidney Care
Quantum Kidney Care Private Limited (QKCPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 January 2004 and has a history of 21 years. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.60 M, as per Ministry of Corporate Affairs (MCA) records.
Ajit Maity and Supriti Maity serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85110WB2004PTC097655
-
Company No.
097655
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Jan 2004
-
Date of AGM
20 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Quantum Kidney Care?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajit Maity
|
Director | 20-Jan-2004 | Current |
|
Supriti Maity
|
Director | 20-Jan-2004 | Current |
Financial Performance of Quantum Kidney Care.
Quantum Kidney Care Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 59.95% decrease. The company also saw a substantial improvement in profitability, with a 37.6% increase in profit. The company's net worth observed a substantial decline by a decrease of 273.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Quantum Kidney Care?
In 2016, Quantum Kidney Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Shivbhakti Properties Private LimitedAjit Maity and Supriti Maity are mutual person
-
Concur Vyapaar Pvt Ltd
Ajit Maity and Supriti Maity are mutual person
-
Sneham Hospital Private Limited
Ajit Maity and Supriti Maity are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Quantum Kidney Care?
Unlock and access historical data on people associated with Quantum Kidney Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Quantum Kidney Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quantum Kidney Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
